Qutenza

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Peripheral NeuropathyAmputation

39 competitors in Peripheral Neuropathy

#DrugCompanyPhaseTrials

1

Cymbalta

Jazz Pharmaceuticals

Approved

92

Lyrica

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

253

Savella

AbbVie

Approved

—4

Neurontin

VViatris Specialty LLC

Approved

35

Accupril

Pfizer

Approved

16

Velcade

SShilpa Grover, MD, MPH

Approved

17

Prilosec

DDexcel Pharma Technologies Ltd.

Approved

—8

Adrucil

EElorac, Inc.

Approved

—9

Journavx

Vertex Pharmaceuticals

Phase 3

210

Cymbalta

Jazz Pharmaceuticals

Phase 3

2Show 23 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Neuropathic Pain3 trials

A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment

Completed·Astellas·Phase 4·NCT01713426·568 enrolled

A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

Completed·Astellas··NCT02171182·319 enrolled

Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain

Completed·—·Phase 2·NCT03317613·84 enrolled

Treatment3 trials

Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch

Completed·Astellas·Phase 4·NCT01416116·122 enrolled

A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients

Completed·Astellas·Phase 3·NCT01478607·468 enrolled

The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain

Completed·UUniversity of Rochester·Phase 2·NCT01260454·6 enrolled

Peripheral Neuropathy1 trial

Qutenza Versus Duloxetine in Chemotherapy-induced Peripheral Neuropathy (CIPN)

Unknown status·—·N/A·NCT05560516·102 enrolled

Amputation1 trial

Pre-emptive Analgesia With Qutenza in Lower Limb Amputation

Unknown status·NNHS Greater Glasgow and Clyde··NCT01748435·30 enrolled

Age1 trial

Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch

Completed·IInstitut de Cancérologie de Lorraine·Phase 3·NCT02822625·69 enrolled

6 more indications

Effectiveness1 trial

Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage

Completed·Astellas·Phase 4·NCT01252160·306 enrolled

Renal Failure1 trial

Qutenza for Critical Ischaemia in End Stage Renal Failure

Unknown status·EEmma Aitken·Phase 4·NCT01704339·20 enrolled

Osteoarthritis1 trial

A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis

Completed·CCentrexion Therapeutics·Phase 1·NCT03576508·16 enrolled

Arteriovenous Fistula1 trial

Qutenza (Topical Capsaicin 8%) for Painful Arteriovenous Fistulae

Unknown status·NNHS Greater Glasgow and Clyde··NCT01748422·20 enrolled

Pulmonary Arterial Hypertension1 trial

Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients

Completed·IImperial College London·Phase 2·NCT01393795·11 enrolled

Peripheral Neuropathy Due to Chemotherapy1 trial

Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study

Recruiting·MM.D. Anderson Cancer Center·Phase 1·NCT06744816·20 enrolled

Details

Drug Info

Related News